Vertical Pharmaceuticals Competitors and Similar CompaniesClear all

Vertical Pharmaceuticals's competitors and similar companies include Abbott, Agile Therapeutics, Ogeda and Ascend Therapeutics.

	Vertical Pharmaceuticals Vertical Pharmaceuticals is a specialty pharmaceutical company.	Abbott Abbott Laboratories is a company that specializes in the discovery, development, manufacture, and sale of healthcare products.	Agile Therapeutics Agile Therapeutics is the pharmaceutical company developing contraceptive healthcare products for women.	Ogeda Ogeda is a clinical-stage drug discovery company that invents and develops small molecule drugs.	Ascend Therapeutics ASCEND Therapeutics is a specialty pharmaceutical company.
Founding Date	Founding Date 2003	Founding Date 1888	Founding Date 1997	Founding Date 1994	Founding Date 1885
Type	Type Subsidiary	Type Public	Type Public	Type Subsidiary	Type Subsidiary
Tags	Tags Healthcare drug development nutrition pharma women's health	Tags Healthcare drug development medical devices medical diagnostics nutrition pharma women's health	Tags Healthcare drug development pharma women's health	Tags Healthcare drug development pharma women's health	Tags Healthcare drug development pharma women's health
Locations	Locations Bridgewater Township, US HQ	Locations Abbott Park, US HQ Tiranë, AL Buenos Aires, AR Yerevan, AM Doncaster, AU East Brisbane, AU Macquarie Park, AU see more	Locations Princeton, US HQ Brentwood, US	Locations Anderlecht, BE HQ	Locations Herndon, US HQ Morristown, US
Employees	Employees 32	Employees 114,000	Employees 1515% increase	Employees 23	Employees 861% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 196.1 b	Valuation ($) 10.4 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $44.3b (FY, 2025)	Revenue (est.) $19.6m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods N/A	Cost of goods $19.3b (FY, 2025)	Cost of goods $9m (FY, 2023)	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit N/A	Gross profit $25b (FY, 2025)	Gross profit $10.6m (FY, 2023)	Gross profit N/A	Gross profit N/A
Net income	Net income N/A	Net income $6.5b (FY, 2025)	Net income ($14.5m) (FY, 2023)	Net income N/A	Net income N/A